Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 236.8K | 610.2K | +373.4K (+157.7%) |
| Value | $70.8K | $214.8K | +$144.0K (+203.5%) |
New holders (3)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 143,791 | $50.8K | 0.00% |
| Two Sigma Securities, LLC | 12,841 | $4.54K | 0.00% |
| Private Management Group Inc | 10,000 | $3.54K | 0.00% |
Sold out (3)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Two Sigma Investments, LP | 10,802 | $3.26K |
| Citigroup Inc | 3,974 | $1.20K |
| Stone House Investment Management, LLC | 2,700 | $816 |